Single anti-HIV
pill approved by the U.S.

Bristol-Myers Squibb Co. said on Friday that U.S. regulators approved a single-capsule form of its Reyataz HIV drug to be taken as part of combination drug therapy. Taken once a day, the 300-milligram Reyataz can replace two 150-milligram capsules of the drug and will be available within a week, the company said. (Reuters)